Northern Trust’s Mural Oncology MURA Stock Holding History

Northern Trust’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,295	Closed	-$68.9K	–	4518
2025 Q3	$68.9K	Sell	33,295 -3,444	-9%	-$7.4K	﹤0.01%	4221
2025 Q2	$90.7K	Sell	36,739 -2,637	-7%	-$6.21K	﹤0.01%	4132
2025 Q1	$49.6K	Sell	39,376 -590	-1%	-$2.15K	﹤0.01%	4232
2024 Q4	$129K	Buy	39,966 +7,197	+22%	+$25.4K	﹤0.01%	4108
2024 Q3	$103K	Sell	32,769 -82,157	-71%	-$268K	﹤0.01%	4048
2024 Q2	$361K	Sell	114,926 -22,057	-16%	-$81.3K	﹤0.01%	3621
2024 Q1	$670K	Sell	136,983 -24,419	-15%	-$119K	﹤0.01%	3466
2023 Q4	$956K	Buy	+161,402	New	+$649K	﹤0.01%	3331

Northern Trust's MURA Position: Q4 2025 in Review

Northern Trust sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 33,295 shares — an estimated $68.9K sold.

Northern Trust first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $956K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Northern Trust reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Northern Trust sold 33,295 Mural Oncology shares in Q4 2025, an estimated $68.9K.
Northern Trust first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Northern Trust's Mural Oncology position peaked at $956K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.